Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

[Production and Identification of Monoclonal Antibody Against Human S100A4.].

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Microsoft Word-Yuan et al PDF

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

Production and Characterization of a Monoclonal Antibody Against GRAM Domain-Containing Protein 1A

Generation of Monoclonal Antibodies for Sensitive Detection of Pro-Inflammatory Protein S100A9

[Preparation and Identification of Monoclonal Antibodies Against SARS-CoV Putative Protein X4].

Preparation and Identification of the Monoclonal Antibody Against Human Bone Sialoprotein

Prokaryotic Expression and Purification of Bioactive Human S100A4

Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology

Production and characterization of a new specific monoclonal antibody against A-isoform of SALL4: A novel emerging testicular cancer marker

[Preparation of the Monoclonal Antibody Against SOX4 Protein and Detection of SOX4 Expression Level in Different Tumor Cell Lines].

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

[Preparation of Anti-B7-h4 Monoclonal Antibody to Investigate B7-H4 Expression in Pancreatic Cancer].

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

Preparation and Characterization of Sialyl - mucin Specific Monoclonal Antibodies and their Immunohistochemical Usage in Gastric Cancer and Colorectal Carcinoma

[Preparation, Purification and Characterization of the Polyclonal Antibody Against Human CMTM4].

Preparation and Identification of Monoclonal Antibody Against C1q/TNF-Related Protein 4.

Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator

Production and Identification of Monoclonal Antibodies to Chcd25

Generation and Characterization of a New Monoclonal Antibody Against CXCL4